Skip to main content
. Author manuscript; available in PMC: 2014 May 5.
Published in final edited form as: J Pharm Pharmacol. 2011 Jul;63(7):967–970. doi: 10.1111/j.2042-7158.2011.01298.x

Figure 1. Structures of model flavones used in the present study.

Figure 1

Shown in the scheme are structures of aglycone forms of hydroxyflavone analogs. Three MHFs were chosen in the experiment. Conjugated forms of flavones with the sulfated metabolites maybe attached to the 7-, 6-, and 4' - positions.